Axxcess Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2M Buy
21,821
+1,455
+7% +$1.49M 0.42% 50
2026
Q1
$18.7M Sell
20,366
-1,982
-9% -$2.01M 0.6% 41
2025
Q4
$23.5M Buy
22,348
+1,408
+7% +$1.35M 0.41% 50
2025
Q3
$16M Buy
20,940
+205
+1% +$153K 0.34% 64
2025
Q2
$16.2M Buy
20,735
+238
+1% +$185K 0.38% 52
2025
Q1
$16.9M Sell
20,497
-3,454
-14% -$2.87M 0.45% 49
2024
Q4
$18.5M Buy
23,951
+1,171
+5% +$970K 0.44% 46
2024
Q3
$20.2M Buy
22,780
+916
+4% +$824K 0.5% 42
2024
Q2
$19.8M Sell
21,864
-2,794
-11% -$2.23M 0.52% 41
2024
Q1
$19.2M Buy
24,658
+981
+4% +$698K 0.53% 37
2023
Q4
$13.8M Buy
23,677
+2,761
+13% +$1.61M 0.4% 51
2023
Q3
$11.2M Buy
20,916
+11,279
+117% +$5.81M 0.38% 57
2023
Q2
$4.52M Sell
9,637
-4,124
-30% -$1.73M 0.33% 71
2023
Q1
$4.73M Sell
13,761
-6,613
-32% -$2.23M 0.36% 65
2022
Q4
$7.45M Buy
20,374
+43
+0.2% +$15.2K 0.61% 33
2022
Q3
$6.57M Buy
20,331
+9,300
+84% +$2.95M 0.62% 30
2022
Q2
$3.58M Buy
11,031
+2,707
+33% +$813K 0.33% 68
2022
Q1
$2.38M Buy
8,324
+1,283
+18% +$330K 0.19% 108
2021
Q4
$1.95M Buy
+7,041
New +$1.78M 0.14% 124

Other funds holding LLY

Axxcess Wealth Management's LLY Position: Q2 2026 in Review

Axxcess Wealth Management increased its Eli Lilly (LLY) stake by 7.1% in Q2 2026, buying an estimated $1.49M and bringing the position to 21,821 shares worth $26.2M. The position accounts for 0.42% of the portfolio, ranked #50.

Axxcess Wealth Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Axxcess Wealth Management held 21,821 shares of Eli Lilly worth $26.2M as of Q2 2026.
  • Axxcess Wealth Management bought 1,455 Eli Lilly shares in Q2 2026, an estimated $1.49M.
  • Eli Lilly made up 0.42% of Axxcess Wealth Management's portfolio in Q2 2026, its #50 holding.
  • Axxcess Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.